Skip to main content

Advertisement

SpringerLink
Log in

Estrogen in obesity-associated colon cancer: friend or foe? Protecting postmenopausal women but promoting late-stage colon cancer

  • Review Article
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Obesity is associated with the increased incidence of colon cancer. Many cancer risk factors have been identified including increased blood levels of insulin, leptin, interleukin-6, interleukin-17, tumor necrosis factor-alpha, and decreased blood levels of adiponectin. However, the role of blood levels of estrogen in obesity-associated colon cancer is controversial. Evidence showed that obesity affected men more strongly than women in the carcinogenesis of colon cancer, indicating protective effect of estrogen which is increased in obesity. However, an epidemiological study has also shown that endogenous estradiol level is an independent risk factor for colon cancer, positively associated with colon cancer after normalizing insulin, IGF-1. The controversial opinions may be caused by different effects of ER-alpha and ER-beta. ER-alpha can increase colon cancer cell proliferation and increase cancer incidence. ER-beta has the opposite effect to ER-alpha, and it causes apoptosis of colon cancer cells. The normal colonocytes mainly express ER-beta. Therefore, increased estrogen in obesity may have protective effect via ER-beta in obesity-associated colon cancer. However, with the development of colon cancer, ER-alpha is increased and ER-beta is decreased. In the late stage of colon cancer, estrogen may promote cancer development via ER-alpha. The different effects and expression of ER-alpha and ER-beta may explain the different results observed in several epidemiological studies as well as several animal experiments. Therefore, manipulation of estrogen-caused signal pathways to inhibit ER-alpha and stimulate ER-beta may have preventive and therapeutic effect for obesity-associated colon cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Renehan AG et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578

    Article  PubMed  Google Scholar 

  2. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591

    Article  PubMed  CAS  Google Scholar 

  3. Gislette T, Chen J (2010) The possible role of IL-17 in obesity-associated cancer. Sci World J 10:2265–2271

    Article  CAS  Google Scholar 

  4. Renehan AG et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418):1346–1353

    Article  PubMed  CAS  Google Scholar 

  5. Chen J et al (2011) Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the PI3 K/Akt pathway. Curr Drug Discov Technol 8(2):119–125

    Article  PubMed  CAS  Google Scholar 

  6. Paz-Filho G et al (2011) Associations between adipokines and obesity-related cancer. Front Biosci 16:1634–1650

    Article  PubMed  CAS  Google Scholar 

  7. Renehan A, Dive C (2011) Obesity, insulin and chemoresistance in colon cancer. J Gastrointest Oncol 2(1):8–10

    PubMed  Google Scholar 

  8. Chen J et al (2011) Insulin caused drug resistance to oxaliplatin in colon cancer cell HT29. J Gastrointest Oncol 2:27–33

    PubMed  Google Scholar 

  9. Chen J (2011) Multiple signal pathways in obesity-associated cancer. Obes Rev 12(12):1063–1070

    Article  PubMed  Google Scholar 

  10. Huang XF, Chen J (2009) Obesity, the PI3 K/Akt signal pathway and colon cancer. Obes Rev 10(6):610–616

    Article  PubMed  CAS  Google Scholar 

  11. Chen J (2012) Targeted therapy of obesity-associated colon cancer. Transl Gastrointest Cancer 1(1):44–57

    Google Scholar 

  12. Murphy TK et al (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152(9):847–854

    Article  PubMed  CAS  Google Scholar 

  13. Ben Q et al (2012) Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142(4):762–772

    Article  PubMed  Google Scholar 

  14. Pischon T et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98(13):920–931

    Article  PubMed  Google Scholar 

  15. Kim BC et al (2012) Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control 23(5):727–735

    Article  PubMed  Google Scholar 

  16. Terry PD, Miller AB, Rohan TE (2002) Obesity and colorectal cancer risk in women. Gut 51(2):191–194

    Article  PubMed  CAS  Google Scholar 

  17. Hou L et al (2006) Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer 42(1):84–90

    Article  PubMed  Google Scholar 

  18. Slattery ML et al (2001) Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61(1):126–130

    PubMed  CAS  Google Scholar 

  19. Sikalidis AK, Varamini B (2011) Roles of hormones and signalling molecules in describing the relationship between obesity and colon cancer. Pathol Oncol Res 17(4):785–790

    Article  PubMed  CAS  Google Scholar 

  20. Gunter MJ et al (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68(1):329–337

    Article  PubMed  CAS  Google Scholar 

  21. English MA et al (1999) Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab 84(6):2080–2085

    Article  PubMed  CAS  Google Scholar 

  22. Lin J et al (2004) Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control 15(6):581–589

    Article  PubMed  Google Scholar 

  23. Di Domenico M et al (1996) Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56(19):4516–4521

    PubMed  Google Scholar 

  24. Narayan S et al (1992) Estradiol is trophic for colon cancer in mice: effect on ornithine decarboxylase and c-myc messenger RNA. Gastroenterology 103(6):1823–1832

    PubMed  CAS  Google Scholar 

  25. Rondini EA et al (2011) Energy balance modulates colon tumour growth: interactive roles of insulin and estrogen. Mol Carcinog 50(5):370–382

    Article  PubMed  CAS  Google Scholar 

  26. Enmark E et al (1997) Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82(12):4258–4265

    Article  PubMed  CAS  Google Scholar 

  27. Menasce LP et al (1993) Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17(1):263–265

    Article  PubMed  CAS  Google Scholar 

  28. Motylewska E, Stasikowska O, Melen-Mucha G (2009) The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer Lett 276(1):68–73

    Article  PubMed  CAS  Google Scholar 

  29. Greene GL et al (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231(4742):1150–1154

    Article  PubMed  CAS  Google Scholar 

  30. Cho MA et al (2007) Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis. J Endocrinol 195(2):255–263

    Article  PubMed  CAS  Google Scholar 

  31. Chow SK, Chan JY, Fung KP (2004) Suppression of cell proliferation and regulation of estrogen receptor alpha signalling pathway by arsenic trioxide on human breast cancer MCF-7 cells. J Endocrinol 182(2):325–337

    Article  PubMed  CAS  Google Scholar 

  32. Nilsson S et al (2001) Mechanisms of estrogen action. Physiol Rev 81(4):1535–1565

    PubMed  CAS  Google Scholar 

  33. de Batistuzzo Medeiros SR (1997) Functional interactions between the estrogen receptor and the transcription activator Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 io promoter. J Biol Chem 272(29):18250–18260

    Article  Google Scholar 

  34. Porter W et al (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11(11):1569–1580

    Article  PubMed  CAS  Google Scholar 

  35. Qin C, Singh P, Safe S (1999) Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 140(6):2501–2508

    Article  PubMed  CAS  Google Scholar 

  36. Webb P et al (1999) The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13(10):1672–1685

    Article  PubMed  CAS  Google Scholar 

  37. Wang C et al (2011) Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Mol Endocrinol 25(9):1527–1538

    Article  PubMed  CAS  Google Scholar 

  38. Bjornstrom L, Sjoberg M (2005) Mechanisms of estrogen receptor signalling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19(4):833–842

    Article  PubMed  Google Scholar 

  39. Hewitt SC et al (2005) Global uterine genomics in vivo: microarray evaluation of the estrogen receptor alpha-growth factor cross-talk mechanism. Mol Endocrinol 19(3):657–668

    Article  PubMed  CAS  Google Scholar 

  40. Simoncini T et al (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407(6803):538–541

    Article  PubMed  CAS  Google Scholar 

  41. Le Romancer M et al (2008) Regulation of estrogen rapid signalling through arginine methylation by PRMT1. Mol Cell 31(2):212–221

    Article  PubMed  Google Scholar 

  42. Yang Z, Barnes CJ, Kumar R (2004) Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells. Clin Cancer Res 10(11):3621–3628

    Article  PubMed  CAS  Google Scholar 

  43. Duan R et al (2001) Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem 276(15):11590–11598

    Article  PubMed  CAS  Google Scholar 

  44. Acconcia F et al (2005) Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signalling. J Cell Physiol 203(1):193–201

    Article  PubMed  CAS  Google Scholar 

  45. La Rosa P et al (2011) 17beta-Estradiol-induced cell proliferation requires estrogen receptor (ER) alpha monoubiquitination. Cell Signal 23(7):1128–1135

    Article  PubMed  Google Scholar 

  46. Marino M, Acconcia F, Trentalance A (2003) Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell 14(6):2583–2591

    Article  PubMed  CAS  Google Scholar 

  47. Song RX et al (2004) The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA 101(7):2076–2081

    Article  PubMed  CAS  Google Scholar 

  48. Zhang Z et al (2004) The role of adapter protein Shc in estrogen non-genomic action. Steroids 69(8–9):523–529

    Article  PubMed  CAS  Google Scholar 

  49. Fernando RI, Wimalasena J (2004) Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signalling through ERK and Akt. Mol Biol Cell 15(7):3266–3284

    Article  PubMed  CAS  Google Scholar 

  50. Marino M et al (2002) Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell 13(10):3720–3729

    Article  PubMed  CAS  Google Scholar 

  51. Bredfeldt TG et al (2010) Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signalling to PI3 K/AKT. Mol Endocrinol 24(5):993–1006

    Article  PubMed  CAS  Google Scholar 

  52. Gustafsson JA (1999) Estrogen receptor beta—a new dimension in estrogen mechanism of action. J Endocrinol 163(3):379–383

    Article  PubMed  CAS  Google Scholar 

  53. Kuiper GG et al (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93(12):5925–5930

    Article  PubMed  CAS  Google Scholar 

  54. Zhao C, Dahlman-Wright K, Gustafsson JA (2010) Estrogen signalling via estrogen receptor {beta}. J Biol Chem 285(51):39575–39579

    Article  PubMed  CAS  Google Scholar 

  55. Galluzzo P et al (2007) Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer 14(1):153–167

    Article  PubMed  CAS  Google Scholar 

  56. Weige CC, Allred KF, Allred CD (2009) Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res 69(23):9118–9124

    Article  PubMed  CAS  Google Scholar 

  57. Edvardsson K et al (2011) Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol 25(6):969–979

    Article  PubMed  CAS  Google Scholar 

  58. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37–40

    Article  PubMed  CAS  Google Scholar 

  59. Dhanasekaran DN, Johnson GL (2007) MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene 26(22):3097–3099

    Article  PubMed  CAS  Google Scholar 

  60. Cuenda A, Rousseau S (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773(8):1358–1375

    Article  PubMed  CAS  Google Scholar 

  61. Porras A et al (2004) P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15(2):922–933

    Article  PubMed  CAS  Google Scholar 

  62. Hui L et al (2007) p38alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 6(20):2429–2433

    Article  PubMed  CAS  Google Scholar 

  63. Shimada K et al (2003) Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 24(6):1067–1075

    Article  PubMed  CAS  Google Scholar 

  64. Hui L et al (2007) p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39(6):741–749

    Article  PubMed  CAS  Google Scholar 

  65. Iwasa H, Han J, Ishikawa F (2003) Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8(2):131–144

    Article  PubMed  CAS  Google Scholar 

  66. Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK (2004) Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res 64(20):7336–7345

    Article  PubMed  CAS  Google Scholar 

  67. Feng Y, Wen J, Chang CC (2009) p38 Mitogen-activated protein kinase and hematologic malignancies. Arch Pathol Lab Med 133(11):1850–1856

    PubMed  CAS  Google Scholar 

  68. Gompel A et al (2004) Steroidal hormones and proliferation, differentiation and apoptosis in breast cells. Maturitas 49(1):16–24

    Article  PubMed  CAS  Google Scholar 

  69. Lin JH et al (2012) Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. Cancer Res 72(12):3020–3028

    Article  PubMed  CAS  Google Scholar 

  70. Tanaka Y et al (2008) Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulating cell cycle-related protein expression. Menopause 15(3):442–453

    Article  PubMed  Google Scholar 

  71. Gizard F et al (2005) Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene. FEBS Lett 579(25):5535–5541

    Article  PubMed  CAS  Google Scholar 

  72. Konstantinopoulos PA et al (2003) Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation. Eur J Cancer 39(9):1251–1258

    Article  PubMed  CAS  Google Scholar 

  73. Qiu Y et al (2002) Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 174(3):369–377

    Article  PubMed  CAS  Google Scholar 

  74. Jassam N et al (2005) Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes’ staging. Oncol Rep 14(1):17–21

    PubMed  CAS  Google Scholar 

  75. Fang YJ et al (2010) Prognostic impact of ERbeta and MMP7 expression on overall survival in colon cancer. Tumour Biol 31(6):651–658

    Article  PubMed  CAS  Google Scholar 

  76. Wong NA et al (2005) ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 207(1):53–60

    Article  PubMed  CAS  Google Scholar 

  77. Wu AH et al (2010) Hormone therapy, DNA methylation and colon cancer. Carcinogenesis 31(6):1060–1067

    Article  PubMed  CAS  Google Scholar 

  78. Lin KJ et al (2012) The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer 130(2):419–430

    Article  PubMed  CAS  Google Scholar 

  79. Hiraoka S et al (2010) Methylation status of normal background mucosa is correlated with occurrence and development of neoplasia in the distal colon. Hum Pathol 41(1):38–47

    Article  PubMed  CAS  Google Scholar 

  80. Anghel A et al (2010) Estrogen receptor alpha polymorphisms and the risk of malignancies. Pathol Oncol Res 16(4):485–496

    Article  PubMed  CAS  Google Scholar 

  81. Worthley DL et al (2010) DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 29(11):1653–1662

    Article  PubMed  CAS  Google Scholar 

  82. Honma et al (2012) Estrogen receptor-beta gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake. Int J Cancer

  83. Saleiro et al (2012) Estrogen receptor-beta protects against colitis-associated neoplasia in mice. Int J Cancer

  84. Gallo D et al (2012) Estrogen receptor beta in cancer: an attractive target for therapy. Curr Pharm Des 18(19):2734–2757

    Article  PubMed  CAS  Google Scholar 

  85. Yi KW et al (2008) Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Obes (Silver Spring) 16(11):2393–2399

    Article  CAS  Google Scholar 

  86. Nejati-Koshki et al (2012) Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology

  87. Mendoza RA et al (2011) Interactions between IGF-I, estrogen receptor-alpha (ERalpha), and ERbeta in regulating growth/apoptosis of MCF-7 human breast cancer cells. J Endocrinol 208(1):1–9

    Article  PubMed  CAS  Google Scholar 

  88. Harris DM et al (2005) Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood) 230(8):558–568

    CAS  Google Scholar 

  89. Schleipen B et al (2011) ERbeta-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine. Carcinogenesis 32(11):1675–1683

    Article  PubMed  CAS  Google Scholar 

  90. Bielecki A et al (2011) Estrogen receptor-beta mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr Cancer 63(1):139–150

    PubMed  CAS  Google Scholar 

  91. Cotterchio M et al (2006) Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136(12):3046–3053

    PubMed  CAS  Google Scholar 

  92. Yang G et al (2009) Prospective cohort study of soy food intake and colorectal cancer risk in women. Am J Clin Nutr 89(2):577–583

    Article  PubMed  CAS  Google Scholar 

  93. Tu Z et al (2012) Estrogen receptor beta potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells. J Cancer Res Clin Oncol 138(7):1091–1103

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Illawarra Health and Medical Research Institute, University of Wollongong, Northfields Ave, Wollongong, NSW, 2522, Australia

    Jiezhong Chen & Don Iverson

Authors
  1. Jiezhong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Don Iverson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jiezhong Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, J., Iverson, D. Estrogen in obesity-associated colon cancer: friend or foe? Protecting postmenopausal women but promoting late-stage colon cancer. Cancer Causes Control 23, 1767–1773 (2012). https://doi.org/10.1007/s10552-012-0066-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-012-0066-z

Keywords

Search

Navigation